Spiro-bridged and non-bridged heterocyclic compounds

摘要

Compounds (I) and (II), including enantiomers, racemates and acid addition and quaternary salts, are for treating diseases of the central and peripheral nervous system, CHEM wherein in formula (I) Q is (CH2)m or C(CH3)2 attached to the 1 min ,4 min or 1 min ,5 min positions of the six-membered ring (m = 1, 2 or 3,) and in formula (II) Q is two hydrogen atoms, (CH2)m or C(CH3)2(m = 1, 2 or 3) and n and p are each independently 0, 1, 2 or 3, provided that n + p = 1-3; R DEG is hydrogen, methyl or OH; CHEM R and R min are independently H, NH2, NH-C1-6-alkyl, N(C1-6-alkyl)2, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-7- cycloalkyl, C1-6-alkyl substituted by 1-6 halogen atoms, HO- C1-6-alkyl, C1-6-alkoxy, C1-6-alkylthio, C1-6-alkoxy-C1-6-alkyl, carboxy-C1-6-alkyl, (C1-6-alkoxy)carbonyl-C1-6-alkyl, amino-C1-6-alkyl, mono-(C1-6-alkyl)amino-C1-6-alkyl, di-(C1-6-alkyl)amino-C1-6-alkyl, 2-oxo-pyrrolidin-1-yl-methyl, Ar, di(Ar)methylol, or (Ar)1-2C1-6-alkyl, or R min may be C1-6-alkanoyl or Arcarbonyl; and Ar denotes Ph optionally substituted by 1-3 of halogen, C1-6-alkyl, C1-6-alkoxy and CF3, subject to certain provisos.